The Australian mission has seen the ASAlaser’s staff engaged on several fronts, first of all the presentation of MLS® Laser Therapy uses and benefits in dentistry. A very tight schedule from 15 to 17 April: visits to loyal customers, new contacts in order to develop partnerships for scientific researches, training days...
April, 15: visits and dinner party
The visit to The Queensland Foot Centres, the medical center that provides the most professional service of podiatry in the state of Queensland, has opened the calendar of meetings. «In this Centre, specialized in sports medicine and already equipped with a Mphi 5 device - explains Giacomo Granozio, ASAlaser’s Area Manager - we have met two podiatrists enthusiastic of the results obtained with MLS® Laser Therapy. They have chosen to explore the operating procedures in order to optimize the therapeutic results». The agenda has continued with a visit to the School of Dentistry at the University of Queensland, nationally and internationally recognized for the high dental education and the contribution to the dental research. The meeting with Professor Lakshman Samaranayake (Head of School of Dentistry) has opened to ASAlaser some possibilities of cooperation to achieve new research in dentistry as well as the visit to the Aesthetic Centre, the dental clinic that has adopted the Mphi D especially for the treatment of neuromuscular pain. The day has ended with a presentation of MLS® Laser Therapy in Dentistry. The "Panorama Room" of the Urban Hotel of Brisbane has hosted, in fact, the first "Dental Dinner Party" organized by the company in collaboration with the local partner Digital Dental. During the meeting, which has also seen the participation of Dr. David Cox (President of the Australian Dental Laser Association) in addition to the 40 dentists from the state of Queensland, have been presented the results obtained with the MLS® Laser Therapy, compared with the therapeutic effects of the traditional laser therapy. Dr. Nghiem Doan (Oral Surgeon, Dental Sedation & Specialist in Public Health Dentistry,) and Lucio Zaghetto, ASAlaser’s CEO have deepened the two themes.
April, 16: in the sign of pain management
Treating pain favoring its management and resolution is one of the goals that ASAlaser’s therapies follow. MLS® Laser Therapy, in fact, has demonstrated its effectiveness in "pain management" as evidenced by many successful cases. ASA’s team has organized an ad hoc evening - "Dinner Party" - to present the use of therapy for this specific purpose. It has been dedicated to podiatrists and chiropractors of private clinics and universities compartments of Queensland.
April, 17: training time
The Australian tour ended with a commercial training focused on therapies devoted to "Pain management" for the local partners Heal With Laser and Medical Laser. «During this visit - Zaghetto concludes – we have started a valid start-up activity for this new country: from the visits to our existing customers to Dinner Party meetings to spread the knowledge of therapies for professionals of dental and pain management sectors as well as training sessions for the sales team of our local partners. We have seen a tremendous enthusiasm and a great desire of all the participants, during all these different appointments, to deepen the knowledge about our therapies in order to achieve the best results. They have also expressed their spontaneous willingness to work with us for training activities and clinical researches».
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.